Literature DB >> 27063857

Visceral obesity, muscle mass and outcome in rectal cancer surgery after neo-adjuvant chemo-radiation.

Colin Heus1, Hamit Cakir1, Arjan Lak1, Hiëronymus J Doodeman2, Alexander P J Houdijk3.   

Abstract

BACKGROUND: Preoperative chemoradiation has become a routine modality in the treatment of rectal carcinoma that may impair a patients general condition. In these patients, it is important to identify factors that influence postoperative recovery. Visceral obesity(VO) as a metabolic risk factor was studied in rectal cancer patients receiving preoperative chemoradiation. AIM: The impact of VO on post-operative outcome in rectal carcinoma surgery after preoperative chemoradiation was studied. In addition, the effect of chemoradiation on body composition was studied.
METHOD: The visceral fat area(VFA), total fat area(TFA) and skeletal muscle area(SMA) were measured on cross-sectional CT-slides in 74 patients who underwent rectal cancer surgery after chemoradiation. CT-scans taken before and after chemoradiation were analysed. Associations between VFA, per- and postoperative complications were studied. A VFA of 100 cm(2) and 130 cm(2) was used to differentiate between non-VO and VO.
RESULTS: Using a VO cut-off point of a VFA of 100 cm(2), the VO patients had more per-operative blood loss(471 mL vs 271 mL p = 0.020), a higher complication rate(10% vs 49% p = 0.001), more ileus(2% vs 28% p = 0.027) and a longer length of stay(9.7days vs 13days p = 0.027). When a VFA of 130 cm(2) was used, VO patients showed more complications(17% vs 55%, p = 0.001) and ileus(10% vs 32% p = 0.017). During chemoradiation the SMA increased(Mean difference: 2.2 cm(2) p = 0.024), while the VFA showed no change.
CONCLUSION: It appears that VO is associated with co-morbidity and poor outcome in rectal cancer patients. Using different cutoff values for VO different associations with outcome were found. SMA increased during chemoradiation, a phenomenon that remains to be explained.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abdominal fat; Chemotherapy; Complications; Outcome; Radiation therapy; Rectum surgery; Visceral fat

Mesh:

Year:  2016        PMID: 27063857     DOI: 10.1016/j.ijsu.2016.03.066

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  11 in total

1.  CT-Quantified Adipose Tissue Distribution: Risk or Protective Factor for Complications after Rectal Cancer Surgery?

Authors:  Johanna Nattenmüller; Jürgen Böhm; Astgik Bagdassarjan; Yakup Kulu; Biljana Gigic; Martin Schneider; Hans-Ulrich Kauczor; Cornelia M Ulrich; Alexis Ulrich
Journal:  Obes Facts       Date:  2019-05-03       Impact factor: 3.942

2.  Impact of Body Composition on Surgical Outcome in Rectal Cancer Patients, a Retrospective Cohort Study.

Authors:  C Heus; N Bakker; W M Verduin; H J Doodeman; A P J Houdijk
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

3.  Risk Factors for Prolonged Postoperative Ileus in Colorectal Surgery: A Systematic Review and Meta-analysis.

Authors:  Andrea Carolina Quiroga-Centeno; Kihara Alejandra Jerez-Torra; Pedro Antonio Martin-Mojica; Sergio Andrés Castañeda-Alfonso; María Emma Castillo-Sánchez; Oscar Fernando Calvo-Corredor; Sergio Alejandro Gómez-Ochoa
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

4.  Does obesity impact postoperative outcomes following robotic-assisted surgery for rectal cancer?

Authors:  E Duchalais; N Machairas; S R Kelley; R G Landmann; A Merchea; D T Colibaseanu; K L Mathis; E J Dozois; D W Larson
Journal:  Surg Endosc       Date:  2018-07-09       Impact factor: 4.584

5.  BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy.

Authors:  Hengchang Liu; Ran Wei; Chunxiang Li; Zhixun Zhao; Xu Guan; Ming Yang; Zheng Liu; Xishan Wang; Zheng Jiang
Journal:  Cancer Manag Res       Date:  2020-10-20       Impact factor: 3.989

6.  Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer.

Authors:  Moon Hyung Choi; Soon Nam Oh; In Kyu Lee; Seong Taek Oh; Daeyoun David Won
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-08-28       Impact factor: 12.910

7.  Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality.

Authors:  Elizabeth M Cespedes Feliciano; Egor Avrutin; Bette J Caan; Adam Boroian; Marina Mourtzakis
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-07-31       Impact factor: 12.910

Review 8.  Relation between skeletal muscle volume and prognosis in rectal cancer patients undergoing neoadjuvant therapy.

Authors:  Paola De Nardi; Alessandro Giani; Giulia Maggi; Marco Braga
Journal:  World J Gastrointest Oncol       Date:  2022-02-15

9.  Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study.

Authors:  Chul Seung Lee; Daeyoun David Won; Soon Nam Oh; Yoon Suk Lee; In Kyu Lee; In-Ho Kim; Moon Hyung Choi; Seong Taek Oh
Journal:  World J Surg Oncol       Date:  2020-08-28       Impact factor: 2.754

10.  CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.

Authors:  Huaiying Su; Junxian Ruan; Tianfeng Chen; Enyi Lin; Lijing Shi
Journal:  Cancer Imaging       Date:  2019-12-03       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.